Renin–angiotensin–aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy
Heart Jan 30, 2018
Huang CY, et al. - Whether treatment with ACE inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs) could lower the risk of new atrial fibrillation (AF) in hypertrophic cardiomyopathy (HCM), was investigated in this study. Treatment of HCM with either ACEIs or ARBs resulted in a lower risk of new AF, when compared with those receiving neither of these medications.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
